|
|||||
ATNAAActive Ingredient(s): Atropine + PralidoximeFirst Approved by the FDA: January 17, 2002 Pharmaceutical Company: US ARMY Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to ATNAAInjection 2.1mg/0.7ml + 600mg/2ml, 2.1mg/0.7ml + 600mg/0.7ml, 2.1mg/0.7ml + 600mg/2ml, 2.1mg/0.7ml,n/a + n/a,600mg/2ml Related Drug Page(s):Other Drugs Containing Atropine or Pralidoxime or a Similar Compund: Related Search Results for ATNAAWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About ATNAA Text Link HTML Code: Related: indications community warnings discuss capsule ATNAA, learn schedule comparison ATNAA, ATNAA headline list, questions withdrawal withdrawal ATNAA, document what is remedy ATNAA, ATNAA national withdrawal educate, research ATNAA, dose reactions facts measure ATNAA, material ATNAA, drug ATNAA. Atropine + Pralidoxime pdr material drugs foreign, Atropine + Pralidoxime druggist tablet, Atropine + Pralidoxime foreign material effect value, forums treat meds listing Atropine + Pralidoxime, Atropine + Pralidoxime natural identification, Atropine + Pralidoxime identify FDA. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/ATNAA.asp Last Updated June 26 2005 |
|||||